LA

Linden Asset Management

North America, Pennsylvania, United States, Philadelphia

Description

Linden Asset Management is a full scale financial services firm that provides an array of services to individual and institutional clients.

Investor Profile

Linden Asset Management has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Pharmaceutical.

Stage Focus

  • Post Ipo Equity (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Linden Asset Management frequently co-invest with?

Iroquois Capital
North America, Tennessee, United States, Nashville
Co-Investments: 1
Northern Rivers Capital Management
North America, Ontario, Canada, Toronto
Co-Investments: 1
TH
North America, California, United States, Menlo Park
Co-Investments: 1
InterGroup
Oceania, Auckland, New Zealand, Auckland
Co-Investments: 1
Alpha Capital
North America, Illinois, United States, Chicago
Co-Investments: 1
Heights Capital Management
North America, California, United States, San Francisco
Co-Investments: 1
Midsummer Capital
North America, New York, United States, New York
Co-Investments: 1
Defiance Capital
North America, New York, United States, New York
Co-Investments: 1
NV
North America, Illinois, United States, Deerfield
Co-Investments: 1
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Linden Asset Management?

Sevion Therapeutics

San Diego, California, United States

Sevion is a biopharmaceutical company which discovers and develops entirely new therapeutic classes for the treatment of cancer.

BiopharmaBiotechnologyPharmaceuticalTherapeutics
Post Ipo EquityMar 29, 2010
Amount Raised: $11,500,000

Find More Investors Like Linden Asset Management

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Linden Asset Management | Pipeseed